beta(2)-Mikroglobulin-associated amyloidosis is a complication of long
-term renal replacement therapy. The present review discusses the curr
ent knowledge on the pathogenesis, clinical manifestations, diagnosis,
prevention and therapy of beta(2)-mikroglobulin-associated amyloidosi
s.